MA
TERN

MYDA Advisors’s Terns Pharmaceuticals TERN Stock Holding History

MYDA Advisors’s Portfolio TERN Stock Details TERN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-10,000
Closed -$83.4K – 193
2024
Q3 		$83.4K Sell
10,000
-30,000
-75% -$247K 0.02% 136
2024
Q2 		$272K Buy
40,000
+9,900
+33% +$60K 0.06% 103
2024
Q1 		$197K Buy
30,100
+10,100
+51% +$66K 0.06% 104
2023
Q4 		$130K Buy
+20,000
New +$106K 0.04% 80

Other funds holding TERN

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

MYDA Advisors's TERN Position: Q2 2026 in Review

MYDA Advisors sold out of Terns Pharmaceuticals (TERN) in Q2 2026, closing a stake of 40,000 shares — an estimated $2.11M sold.

MYDA Advisors first reported a position in TERN in Q4 2023 and held it in 5 quarters. The position peaked at $2.11M in Q1 2026. 1 fund tracked by Wall St. Rank holds TERN as of Q2 2026.

  • MYDA Advisors reported no remaining Terns Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • MYDA Advisors sold 40,000 Terns Pharmaceuticals shares in Q2 2026, an estimated $2.11M.
  • MYDA Advisors first reported a position in Terns Pharmaceuticals in Q4 2023 and held it in 5 quarters.
  • MYDA Advisors's Terns Pharmaceuticals position peaked at $2.11M in Q1 2026.
  • 1 fund tracked by Wall St. Rank held Terns Pharmaceuticals as of Q2 2026.

Based on MYDA Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.